COR
COR
US03073E1055
Cencora, Inc.
Loading chart...

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Latest News

Related stocks

CAH
CAH • United States
Cardinal Health, Inc.
237.57 USD
55.01B USD 1Y +51.5%
MCK
MCK • United States
McKesson Corporation
938.84 USD
109.46B USD 1Y +23.1%
HSIC
HSIC • United States
Henry Schein, Inc.
84.01 USD
9.57B USD 1Y +30.7%
SIG.AX
SIG.AX • Australia
SIGMAHEALT FPO [SIG]
2.69 AUD
21.62B USD 1Y -10.9%
BSX
BSX • United States
Boston Scientific Corporation
42.73 USD
61.93B USD 1Y -56.6%
HUM
HUM • United States
Humana Inc.
431.87 USD
51.86B USD 1Y +29.9%
601607.SS
601607.SS • China
SHANGHAI PHARMACEUTICALS HOLDIN
16.68 CNY
9.26B USD 1Y -8.8%
1099.HK
1099.HK • China
SINOPHARM
14.87 HKD
5.91B USD 1Y -20.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
5Y Volatility
22.9% p.a.
Max Drawdown (5Y)
-32.6%
Sharpe Ratio (5Y)
0.85
Beta Factor
0.58
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 447%.
ende